Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Comparison of MR Enteroclysis and MRI With Per Oral Contrast Using a 6 % Mannitol Solution.
This study is ongoing, but not recruiting participants.
Sponsored by: University of Oslo
Information provided by: University of Oslo
ClinicalTrials.gov Identifier: NCT00204165
  Purpose

The purpose of this study is to compare MRI enteroclysis with MRI of the small bowel with a per oral 6%mannitol solution.Our hypothesis is that the peroral technique preform the same way as MRI Enteroclysis.


Condition Intervention Phase
Magnetic Resonance Imaging, Intestine Small, Crohn Disease.
Procedure: MRI of the small bowel
Phase III

Genetics Home Reference related topics: Crohn disease
MedlinePlus related topics: Crohn's Disease
Drug Information available for: Mannitol
U.S. FDA Resources
Study Type: Interventional
Study Design: Diagnostic, Randomized, Open Label, Uncontrolled, Crossover Assignment
Official Title: MRI of the Small Bowel. Comparison of Different Techniques and Contrast.

Further study details as provided by University of Oslo:

Estimated Enrollment: 40
Study Start Date: November 2004
Estimated Study Completion Date: June 2005
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • above 18 years
  • known Crohns disease or strong suspicion.
  • need of a small bowel examination

Exclusion Criteria:

  • pregnant
  • electrolyte disturbances.
  • Any MRI contraindications.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00204165

Locations
Norway, Oslo
Ulleval Universitets sykehus
Kirkeveien 166, Oslo, Norway, 0407
Sponsors and Collaborators
University of Oslo
Investigators
Study Director: Nils-Einar Kløw, Prof. MD Ulleval Universitetssykehus
  More Information

Study ID Numbers: 431-04150
Study First Received: September 13, 2005
Last Updated: September 7, 2006
ClinicalTrials.gov Identifier: NCT00204165  
Health Authority: Norway: Directorate for Health and Social Affairs

Study placed in the following topic categories:
Digestive System Diseases
Mannitol
Gastrointestinal Diseases
Crohn Disease
Inflammatory Bowel Diseases
Gastroenteritis
Intestinal Diseases

ClinicalTrials.gov processed this record on January 16, 2009